OSTEONECROSI DELLA MANDIBOLA

Size: px
Start display at page:

Download "OSTEONECROSI DELLA MANDIBOLA"

Transcription

1 OSTEONECROSI DELLA MANDIBOLA OSTEONECROSIS OF THE JAWS (ONJ) Paolo Vescovi DDS, MSc Professore Associato di Clinica Odontostomatologica Direttore EMDOLA (European Master Degree on Oral Laser Applications) Università degli Studi di Parma BISPHOSPHONATE THERAPY (BPT) ONJ - BPT ONJ 250 ONJ july ONJ AND Osteonecrosis AND Osteonacrosis of the jaws AND july Osteonecrosis of the jaws 1

2 WIKIPEDIA wiki - vocabolo hawaiano = veloce pedia - suffisso di enciclopedia salute VERO Novembre 2007 Febbraio 2008 L Espresso Marzo 2008 Radio Dee Jay Maggio 2008????? ANCORA MOLTI DUBBI 2

3 Non omogeneità di denominazione:? osteochemonecrosis bisphosphonate osteochemonecrosis of the jaws Bis-Phossy Jaw avascular osteonecrosis bisphosphonate-induced osteopetrosis OSTEONECROSI DELLA MANDIBOLA ONJ-BP (osteonecrosis of the jaws and bisphosphonate) ONJ-BPT (osteonecrosis of the jaws bisphosphonate treatment related) BON (bisphosphonate associated osteonecrosis) BAJO (bisphosphonate associated jaw osteonecrosis) BRON (bisphosphonate-related ostenecrosis) BRONJ (bisphosphonate-related ostenecrosis of the jaw) BONJ (bisphosphonate-associated osteonecrosis of the jaw ) ESPERIENZA DELL AMBULATORIO DI PATOLOGIA E CHIRURGIA ORALE LASER ASSISTITA DELL UNIVERSITA DI PARMA Gennaio 2004 Agosto PAZIENTI AFFETTI DA BRONJ: SEDI MANDIBOLARE 73 (66,4%) MASCELLARE 27 (24,5 %) CONTEMPORANEE 10 (9%) OSTEONECROSI DEI MASCELLARI BRONJ 3

4 BRONJ: Bisphosphonate-Related Osteonecrosis of the Jaws MULTIFACTORIAL PATHOGENESIS STORIA EPIDEMIOLOGIA ASPETTI CLINICI ASPETTI RADIOLOGICI A critical review of the literature reveals that the etiology of ONJ remains unknown and to date no direct causal link to bisphosphonates has been established. Multifactorial pathogenesis FATTORI DI RISCHIO Migliorati CA: Lancet Oncol 2006;7: TERAPIA BRONJ Silverman SL, Landesberg R: Osteonecrosis of the jaw and role of bisphosphonates: a critical review. The American Journal of Medicine 2009 Feb122(24): Migliorati CA, Siegel MA, Elting LS: Bisphosphonate-associated osteonecrosis: a long term complication of bisphosphonate treatment. Lancet Oncol 2006 June (7) BONE REMODELLING SUPRESSION In humans intracortical remodelling rates of the jaw are times higher than inside the cortex of the iliac creste Daily oral alendronate significantly suppressed the intracortical bone formation rate of the mandible in particular in the alveolar region Allen MR. and Burr DB: J Oral Maxillfac Surg 67, 2009 suppl 1. EFFECTS ON THE OSTEOCYTES BPs accumulate in the osteocyte lacunae Regions of non viable bone matrix : the osteocyte network filled with minerals Most often observed in the alveolar portion of the jaws Han ZH, Palmikar S, Rao DS et al: Effects of ethnicicy and age of menopause on the remodeling and turnover of the iliac bone: implications of mechanisms of bone loss. J Bone Mineral Res 1997;12:498 Allen MR, Burr DB: Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008;66:987 Allen MR. and Burr DB: J Oral Maxillfac Surg 67, 2009 suppl 1. Allen MR, Burr DB: Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008;66:987 4

5 ANGIOGENESIS SUPRESSION Each bone remodelling unit (Basic Multicellular Units:BMU) receives its nutrients through vessels. Bone remodelling and angiogenesis are intimately linked Role of altered angiogenesis related to difficult wound healing of soft tissues Disruption of clot and provisional matrix formation in the post extractive sockets Reduction of blood flow in the mandible Allen MR, Burr DB: The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009; suppl 1,67:61-70 ROLE OF BACTERIAL INFECTION TOXIC EFFECTS ON THE SOFT TISSUE BPs which accumulate in the bone have direct toxic effects on the oral epithelium and inhibit normal healing of soft tissue around the lesions caused by invasive dental interventions. BPs induces the death of fibroblasts and epithelial cells by combined intrinsic and extrinsic pathway of apoptosis Reid IR, Bolland MJ: Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007;41: Landesberg R, Cozin M, Cremers S, Woo V et val: Inhibition of oral mucosa cell wound healing by bisphosphonates. J Oral Maxillofac Surg 2008;66, Scheper MA, Badros A, Chaisuparat R et al: Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. British Journal of Haematology 2008, Nov;144: STORIA Settembre descrizione di ONJ-BPT Biofilm on the bone/tooth/mucosal surfaces: Actinomyces Unclear if the infection is a primary or secondary event in BRONJ pathophysiology Sedghizadeh PP, Kumar SK, Gorur A et al: Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 2008;66,767 Marx RE: Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws. A growing epidemic. J Oral Maxillofac Surg 2003,61:

Dental Issues In Cancer Patients Using Bone Modifying Agents What Every GPO Must Know

Dental Issues In Cancer Patients Using Bone Modifying Agents What Every GPO Must Know Dental Issues In Cancer Patients Using Bone Modifying Agents What Every GPO Must Know Dr. Allan Hovan, DMD, MSD, FRCD (C) 2016 CAGPO Annual Meeting Four Seasons Hotel, Vancouver, B.C. Sunday, October 2

More information

Title: Osteoporosis and bisphosphonates related osteonecrosis of the jaw bone

Title: Osteoporosis and bisphosphonates related osteonecrosis of the jaw bone Title: Osteoporosis and bisphosphonates related osteonecrosis of the jaw bone Authors: Alessandro Villa 1, Stefano Castiglioni 1, Alessandro Peretti 1, Marco Omodei 1, Giovanni B Ferrieri 1, Silvio Abati

More information

Alessandria 23 Giugno Osteonecrosi dei mascellari (ONJ): Prevenzione, Diagnosi, Trattamento Update 2009

Alessandria 23 Giugno Osteonecrosi dei mascellari (ONJ): Prevenzione, Diagnosi, Trattamento Update 2009 Alessandria 23 Giugno 2009 Osteonecrosi dei mascellari (ONJ): Prevenzione, Diagnosi, Trattamento Update 2009 ONJ anche se l osso non è esposto? Prof. Michele D. Mignogna, MD, DDS FEDERICO II UNIVERSITY

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 119 No 1246 ISSN 1175 8716 Osteonecrosis of the jaw and bisphosphonates putting the risk in perspective Mark Bolland, David Hay, Andrew Grey, Ian Reid, Tim Cundy Abstract

More information

OSTEONECROSIS OF THE JAW BONES IN PATIENTS TREATED WITH BISPHOSPHONATES FOR MULTIPLE MYELOMA

OSTEONECROSIS OF THE JAW BONES IN PATIENTS TREATED WITH BISPHOSPHONATES FOR MULTIPLE MYELOMA CASE SERIES OSTEONECROSIS OF THE JAW BONES IN PATIENTS TREATED WITH BISPHOSPHONATES FOR MULTIPLE MYELOMA F A VOHRA, M A SHEIKH ABSTRACT Key words Bisphosphonates, particularly those administered through

More information

The effects of osteoclast modifiers on the oral cavity: a review for prescribers

The effects of osteoclast modifiers on the oral cavity: a review for prescribers REVIEW C URRENT OPINION The effects of osteoclast modifiers on the oral cavity: a review for prescribers Matthew S. Epstein a, Joel B. Epstein b, and Hillel D. Ephros c,d Purpose of review Osteonecrosis

More information

University Hospital of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria.

University Hospital of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria. ORIGINAL ARTICLE TREATMENT RESULTS OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAWS Arno Wutzl, MD, DMD, Edwin Biedermann, MD, Felix Wanschitz, MD, DMD, PhD, Rudolf Seemann, MD, Clemens Klug, MD, DMD,

More information

NIH Public Access Author Manuscript J Oral Maxillofac Surg. Author manuscript; available in PMC 2009 May 1.

NIH Public Access Author Manuscript J Oral Maxillofac Surg. Author manuscript; available in PMC 2009 May 1. NIH Public Access Author Manuscript Published in final edited form as: J Oral Maxillofac Surg. 2008 May ; 66(5): 987 994. Mandible matrix necrosis in beagle dogs After 3-years of daily oral bisphosphonate

More information

Clinical Study Bisphosphonate Related Osteonecrosis of the Jaw: A Study of 18 Cases Associated with Fungal Infection

Clinical Study Bisphosphonate Related Osteonecrosis of the Jaw: A Study of 18 Cases Associated with Fungal Infection International Dentistry, Article ID 869067, 5 pages http://dx.doi.org/10.1155/2014/869067 Clinical Study Bisphosphonate Related Osteonecrosis of the Jaw: A Study of 18 Cases Associated with Fungal Infection

More information

Cara B. Gonzales, DDS, PhD. Assistant Professor Department of Comprehensive Dentistry UTHSCSA Dental School

Cara B. Gonzales, DDS, PhD. Assistant Professor Department of Comprehensive Dentistry UTHSCSA Dental School Cara B. Gonzales, DDS, PhD Assistant Professor Department of Comprehensive Dentistry UTHSCSA Dental School March 30, 2010 1 st annual STOHN Convocation 16 Community Clinicians 15 Investigators Bisphosphonate-associated

More information

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible J Oral Maxillofac Surg 69:114-119, 2011 Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible Patrick G. Morris, MD,* Clifford Hudis, MD, Jorge Carrasquillo, MD, Steven Larson, MD,

More information

Closure of an Open Wound Associated with Bisphosphonate-Related Osteonecrosis of the Jaw in a Breast Cancer Patient

Closure of an Open Wound Associated with Bisphosphonate-Related Osteonecrosis of the Jaw in a Breast Cancer Patient The Open Dentistry Journal, 2011, 5, 163-167 163 Open Access Closure of an Open Wound Associated with Bisphosphonate-Related Osteonecrosis of the Jaw in a Breast Cancer Patient Nafiseh Soolari 1 and Ahmad

More information

Non-commercial use only

Non-commercial use only Reumatismo, 2017; 69 (1): 9-15 Drug-induced osteonecrosis of the jaw: the state of the art A. Fassio 1, F. Bertoldo 2, L. Idolazzi 1, O. Viapiana 1, M. Rossini 1, D. Gatti 1 1 Department of Medicine, Rheumatology

More information

Osteonecrosis of the jaw (ONJ)

Osteonecrosis of the jaw (ONJ) Osteonecrosis of the jaw (ONJ) This Infosheet explains what osteonecrosis of the jaw (ONJ) is, a rare condition related to long-term treatment with drugs known as bisphosphonates. What is ONJ? ONJ is a

More information

From Fragile to Firm. Monika Starosta MD. Advocate Medical Group

From Fragile to Firm. Monika Starosta MD. Advocate Medical Group From Fragile to Firm Monika Starosta MD Advocate Medical Group Bone Remodeling 10% remodeled each year Calcium homoeostasis Maintain Mechanical strength Replace Osteocytes Release Growth Factors Bone remodeling

More information

Talib A. Najjar, DMD, MDS, PhD Professor Oral & Maxillofacial Surgery Rutgers University

Talib A. Najjar, DMD, MDS, PhD Professor Oral & Maxillofacial Surgery Rutgers University Talib A. Najjar, DMD, MDS, PhD Professor Oral & Maxillofacial Surgery Rutgers University 1 Biochemistry Interaction with Oral & Systemic Diseases Periodontal disease Jaw Bone Necrosis due to Bisphosphonate

More information

Osteonecrosis of the Jaw in the United States Food and Drug Administration s Adverse Event Reporting System (FAERS)

Osteonecrosis of the Jaw in the United States Food and Drug Administration s Adverse Event Reporting System (FAERS) ORIGINAL ARTICLE JBMR Osteonecrosis of the Jaw in the United States Food and Drug Administration s Adverse Event Reporting System (FAERS) Xiaoyan Zhang, 1 Issam S Hamadeh, 2,3 Shuang Song, 2 Joseph Katz,

More information

Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates

Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates Imaging Science in Dentistry 2017; 47: 45-50 https://doi.org/10.5624/isd.2017.47.1.45 Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates Ho-Gul

More information

Abstract. Osteonecrosis of the jaw (ONJ)

Abstract. Osteonecrosis of the jaw (ONJ) ca Applied Research Cite this article as: J Can Dent Assoc 2010;76:aXXX 2011;77:b147 Preventive Strategies and Clinical Implications for Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of 282

More information

The Impact of Bisphosphonate in Dental Practice

The Impact of Bisphosphonate in Dental Practice The Impact of Bisphosphonate in Dental Practice Talib A. Najjar,DMD,MDS,PhD Professor OMF Surgery UMDNJ-Uneversity Hospital Newark,NJ,USA BIONJ is a big Problem Now it is tip of the iceberg Exposed, non-healing

More information

The Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian Case Series

The Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian Case Series J Oral Maxillofac Surg 68:337-343, 2010 The Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian Case Series Alastair Goss, DDSc, FRACDS(OMS),*

More information

Osteonecrosis of the jaw associated with the use of oral biphosphonates: apropos five cases

Osteonecrosis of the jaw associated with the use of oral biphosphonates: apropos five cases 37 Marín Fernández AB 1, Arjona Giménez C 2, de Dios Navarrete J 2 1 Servicio de Cirugía Oral y Maxilofacial - H. U. Virgen de las Nieves - Granada. Xanit Hospital Internacional - Benalmádena - Málaga

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 ACTONEL 5 mg, film-coated tablet B/14 (CIP code: 354 362-3) ACTONEL 30 mg, film-coated tablet B/28 (CIP

More information

Maddalena Manfredi 1, Giovanni Mergoni 1, Matteo Goldoni 2, Stefania Salvagni 3, Elisabetta Merigo 1, Marco Meleti 1, Paolo Vescovi 1

Maddalena Manfredi 1, Giovanni Mergoni 1, Matteo Goldoni 2, Stefania Salvagni 3, Elisabetta Merigo 1, Marco Meleti 1, Paolo Vescovi 1 Journal section: Medically compromised patients in Dentistry Publication Types: Research doi:10.4317/medoral.21728 http://dx.doi.org/doi:10.4317/medoral.21728 A 5-year retrospective longitudinal study

More information

Intralesional biological glue - a new perspective for the prevention of bisphosphonate-induced osteochemonecrosis of the jaw

Intralesional biological glue - a new perspective for the prevention of bisphosphonate-induced osteochemonecrosis of the jaw Clinical Intralesional biological glue - a new perspective for the prevention of bisphosphonate-induced osteochemonecrosis of the jaw Carine Tabarani, 1 Fawzi Riachi, 2 Sophie Lejeune 3 Abstract Bisphosphonates

More information

What Lung Cancer Patients Need to Know About Bone Health. A Publication of The Bone and Cancer Foundation

What Lung Cancer Patients Need to Know About Bone Health. A Publication of The Bone and Cancer Foundation What Lung Cancer Patients Need to Know About Bone Health A Publication of The Bone and Cancer Foundation Contents THIS PUBLICATION PROVIDES IMPORTANT INFORMATION ABOUT THE RELATIONSHIP BETWEEN LUNG CANCER

More information

Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking

Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking Arezo Tardast, Reine Sjoman, Sigbjorn Loes and Jahan Abtahi Linköping University Post

More information

Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth Extraction

Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth Extraction J Oral Maxillofac Surg 68:797-804, 2010 Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth Extraction Giorgia Saia, MD,* Stella Blandamura, MD, Giordana Bettini, MD, Anita

More information

Effects of Bisphosphonates on the Jaw Bones

Effects of Bisphosphonates on the Jaw Bones Effects of Bisphosphonates on the Jaw Bones Kugarubani Krishnan Final year B.D.S Student,Department Of Oral And Maxillofacial Surgery.Saveetha Dental College Dr. M.P.Santhosh Kumar M.D.S. * Reader,Department

More information

Mehmet Ali-Erdem 1, Abdulkadir Burak-Cankaya 1, Sabri Cemil-Isler 1, Sabit Demircan 1, Merva Soluk 2, Cetin Kasapoglu 3, Cuneyt Korhan-Oral 3

Mehmet Ali-Erdem 1, Abdulkadir Burak-Cankaya 1, Sabri Cemil-Isler 1, Sabit Demircan 1, Merva Soluk 2, Cetin Kasapoglu 3, Cuneyt Korhan-Oral 3 Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.17150 http://dx.doi.org/doi:10.4317/medoral.17150 : Animal model for bisphosphonate related osteonecrosis of

More information

Potential Pathophysiological Mechanisms in Osteonecrosis of the Jaw

Potential Pathophysiological Mechanisms in Osteonecrosis of the Jaw University of Connecticut DigitalCommons@UConn Articles - Research University of Connecticut Health Center Research 2-2011 Potential Pathophysiological Mechanisms in Osteonecrosis of the Jaw Regina L.

More information

CIC Edizioni Internazionali

CIC Edizioni Internazionali Eu/it Multicenter Studies (On/OFF) and the doctoral System for OnJ O. di Fede Università degli Studi di Palermo The aim of the presentation is to describe two new technological projects applied in the

More information

Denosumab-related osteonecrosis of the jaw: A literature review Martwica kości szczęk wywołana denozumabem przegląd piśmiennictwa

Denosumab-related osteonecrosis of the jaw: A literature review Martwica kości szczęk wywołana denozumabem przegląd piśmiennictwa Reviews Denosumab-related osteonecrosis of the jaw: A literature review Martwica kości szczęk wywołana denozumabem przegląd piśmiennictwa Gianfilippo Nifosì 1,A F, Antonio Fabrizio Nifosì 2,A F, Lorenzo

More information

Bisphosphonates, inhibitors of osteoclasts, have

Bisphosphonates, inhibitors of osteoclasts, have ABSTRACT Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy Strategies for prevention and early recognition MAICO D. MELO, D.M.D.; GEORGE OBEID, D.D.S. Bisphosphonates,

More information

MRI evaluation of bisphosphonate-related osteonecrosis of the jaw

MRI evaluation of bisphosphonate-related osteonecrosis of the jaw MRI evaluation of bisphosphonate-related osteonecrosis of the jaw Poster No.: C-1949 Congress: ECR 2012 Type: Authors: Keywords: DOI: Scientific Paper G. Filonzi, A. Bazzocchi, P. Spinnato, E. Salzzoni;

More information

The effect of zoledronic acid on growth plates and high turnover bones

The effect of zoledronic acid on growth plates and high turnover bones DOI: 10.4149/BLL_2014_028 EXPERIMENTAL STUDY The effect of zoledronic acid on growth plates and high turnover bones Erdogan M 1, Bereket C 2, Ozkan N 2, Alici O 3, Sener I 2, Desteli EE 4, Ilkaya F 5 Department

More information

Potential pathophysiological mechanisms in osteonecrosis of the jaw

Potential pathophysiological mechanisms in osteonecrosis of the jaw Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Bisphosphonates and Osteonecrosis of the Jaw Potential pathophysiological mechanisms in osteonecrosis of the jaw Regina

More information

Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review

Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review doi: 10.1111/j.1600-0714.2007.00540.x J Oral Pathol Med (2007) 36: 319 28 ª 2007 The Authors. Journal compilation ª 2007 Blackwell Munksgaard Æ All rights reserved www.blackwellmunksgaard.com/jopm REVIEW

More information

Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates Basic research Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates Marcin Kos Department of Maxillofacial Surgery, Klinikum Minden, Minden,

More information

The following resources related to this article are available online at jada.ada.org ( this information is current as of August 12, 2011):

The following resources related to this article are available online at jada.ada.org ( this information is current as of August 12, 2011): Microbial Biofilms in Osteomyelitis of the Jaw and Osteonecrosis of the Jaw Secondary to Bisphosphonate Therapy Parish P. Sedghizadeh, Satish K.S. Kumar, Amita Gorur, Christoph Schaudinn, Charles F. Shuler

More information

Osteonecrosis of the Jaw Onset Times Are Based on the Route of Bisphosphonate Therapy

Osteonecrosis of the Jaw Onset Times Are Based on the Route of Bisphosphonate Therapy PATHOLOGY J Oral Maxillofac Surg 71:513-519, 2013 Osteonecrosis of the Jaw Onset Times Are Based on the Route of Bisphosphonate Therapy Kenneth E. Fleisher, DDS,* Anu Jolly, Uma Deepthi Chippada Venkata,

More information

Analysis of bone activity of jaws using scintigraphy on patients before, during and after treatment with IV bisphosphonates: a retrospective study

Analysis of bone activity of jaws using scintigraphy on patients before, during and after treatment with IV bisphosphonates: a retrospective study University of Iowa Iowa Research Online Theses and Dissertations Spring 2009 Analysis of bone activity of jaws using scintigraphy on patients before, during and after treatment with IV bisphosphonates:

More information

Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017

Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017 Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017 Introduction A fracture due to OP occurs every 3 seconds around the world. 1

More information

A Probable Case of Oral Bisphosphonate-Associated Osteonecrosis of the Jaw and Recovery with Parathyroid Hormone Treatment

A Probable Case of Oral Bisphosphonate-Associated Osteonecrosis of the Jaw and Recovery with Parathyroid Hormone Treatment VOLUM 69, NUMBR 4, AUGUST 2oo8 Case Report A Probable Case of Oral Bisphosphonate-Associated Osteonecrosis of the Jaw and Recovery with Parathyroid Hormone Treatment Kyung-un Song, MD1; Yong-Ki Min, MD,

More information

Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy

Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy Article ID: WMC002619 2046-1690 Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy Corresponding Author: Dr. Vinod K Dayma, Senior Demonstrator, Dept. of Dental Anatomy and Histology,

More information

Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm

Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm N. Malden, 1 C. Beltes 2 and V. Lopes 3 VERIFIABLE CPD PAPER IN BRIEF A method of placing patients into

More information

Oral Bisphosphonates and the Risk for Osteonecrosis of the Jaw

Oral Bisphosphonates and the Risk for Osteonecrosis of the Jaw BJMP 2009:2(2) 11- Review Article Oral Bisphosphonates and the Risk for Osteonecrosis of the Jaw Nasseer A Masoodi Abstract Several recent reports have described osteonecrosis of the jaws (ONJ) associated

More information

Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons

Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons ALIYA A. KHAN, LORENA P. RIOS, GEORGE K.B. SÁNDOR, NAZIR KHAN, EDMUND PETERS, MOHAMMED O. RAHMAN,

More information

For the Patient: Bisphosphonates and Oral Health in Multiple Myeloma

For the Patient: Bisphosphonates and Oral Health in Multiple Myeloma For the Patient: Bisphosphonates and Oral Health in Multiple Myeloma Regular dental care is very important for all cancer patients. As soon as possible after your cancer diagnosis, your dentist should

More information

Bisphosphonate-Related Jaw Necrosis Part 1: Background, Incidence and Risk Factors

Bisphosphonate-Related Jaw Necrosis Part 1: Background, Incidence and Risk Factors Quality Resource Guide MetLife designates this activity for 1.5 continuing education credit for the review of this Quality Resource Guide and successful completion of the post test. Bisphosphonate-Related

More information

osteonecrosis of the jaw (BRONJ) in a large cohort. Materials and Methods: A retrospective cohort multicenter study was designed.

osteonecrosis of the jaw (BRONJ) in a large cohort. Materials and Methods: A retrospective cohort multicenter study was designed. J Oral Maxillofac Surg 70:2501-2507, 2012 Resective Surgical Approach Shows a High Performance in the Management of Advanced Cases of Bisphosphonate-Related Osteonecrosis of the Jaws: A Retrospective Survey

More information

Monitoring therapy and mitigating side effects

Monitoring therapy and mitigating side effects Monitoring therapy and mitigating g side effects Noopur Raje, MD Director, Center for Multiple Myeloma MGH Cancer Center Associate Professor of Medicine Harvard Medical School Issues with BP Therapy Renal

More information

Extraction Socket Healing in Pediatric Patients. Treated with Intravenous Pamidronate

Extraction Socket Healing in Pediatric Patients. Treated with Intravenous Pamidronate Extraction Socket Healing in Pediatric Patients Treated with Intravenous Pamidronate Carol J. Chahine Department of Oral and Maxillofacial Surgery McGill University, Montreal August, 2011 A thesis submitted

More information

Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy

Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy PRESENTACIÓN DE CASO Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy Osteonecrosis severa de los maxilares asociada al uso de bifosfonatos Juliana Dreyer de

More information

Medical Advances and Their Impact on Dental Patient Management: A Historical and Evidence-Based Discussion

Medical Advances and Their Impact on Dental Patient Management: A Historical and Evidence-Based Discussion Medical Advances and Their Impact on Dental Patient Management: A Historical and Evidence-Based Discussion Tam T Van, DDS Clinical Assistant Professor, Comprehensive Dentistry University of Texas Health

More information

Clinical Study Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients

Clinical Study Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients International Dentistry Volume 2014, Article ID 427273, 7 pages http://dx.doi.org/10.1155/2014/427273 Clinical Study Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple

More information

Is oral bisphosphonate therapy a risk factor for implant failure?

Is oral bisphosphonate therapy a risk factor for implant failure? C L I N I C A L Is oral bisphosphonate therapy a risk factor for implant failure? Johan Hartshorne 1 A critical appraisal of a systematic review: Ata-Ali J, Ata-Ali F, Peñarrocha-Oltra D, Galindo-Moreno

More information

ANATOMY OF THE PERIODONTIUM. Dr. Fatin Awartani

ANATOMY OF THE PERIODONTIUM. Dr. Fatin Awartani ANATOMY OF THE PERIODONTIUM Part II Cementum and Alveolar bone Associate Professor Periodontal division King Saud university Cementum Calcified mesenchymal tissue that forms the outer covering of the anatomic

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS The following questions are representative of questions that patients and family members ask when they visit the Bone and Cancer Foundation website or contact the Foundation

More information

DRUG-RELATED OSTEONECROSIS OF THE JAW

DRUG-RELATED OSTEONECROSIS OF THE JAW DRUG-RELATED OSTEONECROSIS OF THE JAW INFORMATION FOR PATIENTS Olga Di Fede and Giuseppina Campisi University of Palermo Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S) Dear Patient

More information

Bisphosphonate-related osteonecrosi Titlein Japanese population: a case seri patients at our clinic. Nomura, T; Shibahara, T; Uchiyama,

Bisphosphonate-related osteonecrosi Titlein Japanese population: a case seri patients at our clinic. Nomura, T; Shibahara, T; Uchiyama, Bisphosphonate-related osteonecrosi Titlein Japanese population: a case seri patients at our clinic. Nomura, T; Shibahara, T; Uchiyama, Shibui, T; Yakushiji, T; Watanabe, Author(s) Ogane, S; Murayama,

More information

Jaw Osteonecrosis Tied To Infusion Exposure.(Clinical Rounds): An Article From: Family Practice News [HTML] [Digital] By Kerri Wachter READ ONLINE

Jaw Osteonecrosis Tied To Infusion Exposure.(Clinical Rounds): An Article From: Family Practice News [HTML] [Digital] By Kerri Wachter READ ONLINE Jaw Osteonecrosis Tied To Infusion Exposure.(Clinical Rounds): An Article From: Family Practice News [HTML] [Digital] By Kerri Wachter READ ONLINE If you are searching for the book Jaw osteonecrosis tied

More information

Head and Neck Imaging Original Research

Head and Neck Imaging Original Research Head and Neck Imaging Original Research García-Ferrer et al. of Mandibular Osteonecrosis Head and Neck Imaging Original Research Luis García-Ferrer 1 Jose V. agán 2 Vicente Martínez-Sanjuan 3 Sergio Hernandez-azan

More information

Review Article Oral Bisphosphonate Related Osteonecrosis of the Jaw: A Challenging Adverse Effect

Review Article Oral Bisphosphonate Related Osteonecrosis of the Jaw: A Challenging Adverse Effect ISRN Rheumatology Volume 2013, Article ID 215034, 6 pages http://dx.doi.org/10.1155/2013/215034 Review Article Oral Bisphosphonate Related Osteonecrosis of the Jaw: A Challenging Adverse Effect Ilke Coskun

More information

Bone metastases in hematology

Bone metastases in hematology Botziekte bij hematologische tumoren Prof. Dr. Michel Delforge Hematologie, UZ Leuven Bone metastases in hematology The bone marrow is the source of many hematological malignancies However, bone damage

More information

Guidelines for the diagnosis of bisphosphonate-related

Guidelines for the diagnosis of bisphosphonate-related Mini-review Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ) Salvatore L. Ruggiero Assistant Professor Department of Oral and Maxillofacial Surgery Stony Brook School

More information

Research Article Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw

Research Article Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw Hindawi International Dentistry Volume 2017, Article ID 3190301, 6 pages https://doi.org/10.1155/2017/3190301 Research Article Radiographic Findings in Patients with Medication-Related Osteonecrosis of

More information

OSTEONECROSIS OF THE LOWER JAW, ASSOCIATED WITH THE APPLICATION OF ORAL BISPHOSPHONATES CASE REPORT

OSTEONECROSIS OF THE LOWER JAW, ASSOCIATED WITH THE APPLICATION OF ORAL BISPHOSPHONATES CASE REPORT OSTEONECROSIS OF THE LOWER JAW, ASSOCIATED WITH THE APPLICATION OF ORAL BISPHOSPHONATES CASE REPORT P. Pechalova 1, A. Bakardjiev 2, B. Vladimirov 1, E. Poriazova 3, Z. Zaprianov 3, I. Angelova 4, A. Zheleva

More information

Bisphosphonates, drugs that decrease bone turnover by inhibiting

Bisphosphonates, drugs that decrease bone turnover by inhibiting ORIGINAL RESEARCH P.M. Phal R.W.T. Myall L.A. Assael J.L. Weissman Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws BACKGROUND AND PURPOSE: Bisphosphonates are drugs that decrease

More information

MRONJ: Medication-Related Osteonecrosis of the Jaw

MRONJ: Medication-Related Osteonecrosis of the Jaw MRONJ: Medication-Related Osteonecrosis of the Jaw Matthew McKnight DDS,MD History 2004, new reports of difficult to treat jaw osteonecrosis associated with bisphosphonates. Bisphosphonate-related Osteonecrosis

More information

Bisphosphonate Related Osteonecrosis: Where are we today and what the future holds?

Bisphosphonate Related Osteonecrosis: Where are we today and what the future holds? Bisphosphonate Related Osteonecrosis: Where are we today and what the future holds? Babak Bina DMD Director of General Practice Residency Lutheran Medical Center Brooklyn Osteonecrosis Bisphosphonates

More information

ORAL MEDICINE. Editor: Craig S. Miller. Vol. 112 No. 2 August 2011

ORAL MEDICINE. Editor: Craig S. Miller. Vol. 112 No. 2 August 2011 Vol. 112 No. 2 August 2011 ORAL MEDICINE Editor: Craig S. Miller Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center

More information

The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla

The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla Journal section: Oral Surgery Publication Types: Review doi:10.4317/medoral.17422 http://dx.doi.org/doi:10.4317/medoral.17422 The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related

More information

wileyonlinelibrary.com/journal/jop

wileyonlinelibrary.com/journal/jop J Oral Pathol Med (2012) 41: 222 228 ª 2011 John Wiley & Sons A/S Æ All rights reserved doi: 10.1111/j.1600-0714.2011.01095.x wileyonlinelibrary.com/journal/jop Multiple myeloma vs. breast cancer patients

More information

Download slides:

Download slides: Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division

More information

A systematic review of bisphosphonate osteonecrosis (BON) in cancer

A systematic review of bisphosphonate osteonecrosis (BON) in cancer Support Care Cancer (2010) 18:1099 1106 DOI 10.1007/s00520-010-0882-1 REVIEW ARTICLE A systematic review of bisphosphonate osteonecrosis (BON) in cancer Cesar Augusto Migliorati & Sook-Bin Woo & Ian Hewson

More information

Prof.ssa Carmen Mortellaro

Prof.ssa Carmen Mortellaro ONJ UPDATE 2018 OSTEONECROSI DELLE OSSA MASCELLARI (ONJ) DA BIFOSFONATI E ALTRI FARMACI: PREVENZIONE, DIAGNOSI, FARMACOVIGILANZA, TRATTAMENTO TRATTAMENTO DELLA ONJ: UPDATE DELLA LETTERATURA (2014-2018)

More information

Bone. Osteonecrosis of the jaw Who gets it, and why? Ian R. Reid. Review. Contents lists available at ScienceDirect

Bone. Osteonecrosis of the jaw Who gets it, and why? Ian R. Reid. Review. Contents lists available at ScienceDirect Bone 44 (2009) 4 10 Contents lists available at ScienceDirect Bone journal homepage: www.elsevier.com/locate/bone Review Osteonecrosis of the jaw Who gets it, and why? Ian R. Reid Faculty of Medical and

More information

Novel therapies for Myeloma bone disease. Dr. Naif AlJohani ABIM,FRCPC Adult Hematology/BMT King Faisal specialist hospital & Research center Jeddah

Novel therapies for Myeloma bone disease. Dr. Naif AlJohani ABIM,FRCPC Adult Hematology/BMT King Faisal specialist hospital & Research center Jeddah Novel therapies for Myeloma bone disease Dr. Naif AlJohani ABIM,FRCPC Adult Hematology/BMT King Faisal specialist hospital & Research center Jeddah 1 Introduction Multiple myeloma (MM) is a plasma cell

More information

Osteoporosis Medications and Oral Health

Osteoporosis Medications and Oral Health Osteoporosis Medications and Oral Health Oral Health Topics Overview There are approximately 10 million Americans aged 50 years or older with osteoporosis and an additional 34 million with low bone mass

More information

Osteoporosis is a skeletal disorder characterized by

Osteoporosis is a skeletal disorder characterized by CLINICAL Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study Tomas Siebert, MD, PhD Richard Jurkovic, MD, PhD Dagmar Statelova,

More information

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws Approved by the Board of Trustees September 25, 2006 Introduction Bisphosphonate-related

More information

Anatomic Site Variability in Rat Skeletal Uptake and Desorption Of Fluorescently Labeled Bisphosphonate

Anatomic Site Variability in Rat Skeletal Uptake and Desorption Of Fluorescently Labeled Bisphosphonate University of Pennsylvania ScholarlyCommons Departmental Papers (Dental) Penn Dental Medicine 5-2011 Anatomic Site Variability in Rat Skeletal Uptake and Desorption Of Fluorescently Labeled Bisphosphonate

More information

The dental implications of bisphosphonates and bone disease

The dental implications of bisphosphonates and bone disease The dental implications of bisphosphonates and bone disease A Cheng,* A Mavrokokki,* G Carter,* B Stein, NL Fazzalari, DF Wilson, AN Goss* Abstract In 2002/2003 a number of patients presented to the South

More information

Objective: The aim of this systematic review was to assess the role of microsurgical

Objective: The aim of this systematic review was to assess the role of microsurgical www.scielo.br/jaos A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis Roberto SACCO 1, Gianluca

More information

Bisphosphonates, oral implants and osteonecrosis of the jaw: a review and guidelines

Bisphosphonates, oral implants and osteonecrosis of the jaw: a review and guidelines Journal of Disability and Oral Health (2010) 11/4 155-162 Bisphosphonates, oral implants and osteonecrosis of the jaw: a review and guidelines Abdulhadi Warreth BDS MDent Sc PhD 1, Najia Ibieyou BDS MDent

More information

Antiresorptive Medications and Your Oral Health

Antiresorptive Medications and Your Oral Health Antiresorptive Medications and Your Oral Health This booklet focuses on preventing and managing oral complications that could arise from the use of antiresorptive medications in patients with cancer or

More information

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014 Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays Suzanne Morin MD FRCP FACP McGill University May 2014 Learning Objectives Overview of osteoporosis management Outline efficacy

More information

Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed

Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed Available online at www.sciencedirect.com British Journal of Oral and Maxillofacial Surgery 53 (2015) 13 17 Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents

More information

Bone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital

Bone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital Bone Metastases Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital 1 Outline Pathophysiology Signs & Symptoms Diagnosis Treatment Spinal Cord Compression 2 General Information

More information

Osteoporosis. Overview

Osteoporosis. Overview v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

Dental professionals have defined osteonecrosis of the

Dental professionals have defined osteonecrosis of the review A Rationale for an Approach to Preventing and Treating Bisphosphonate-related Osteonecrosis of the Jaw With Vitamin K 2 Menaquinone-4 John Neustadt, ND; Steve Pieczenik, MD, PhD Abstract In this

More information

NAMS Practice Pearl. Use of Drug Holidays in Women Taking Bisphosphonates. Released April 1, 2013

NAMS Practice Pearl. Use of Drug Holidays in Women Taking Bisphosphonates. Released April 1, 2013 NAMS Practice Pearl Use of Drug Holidays in Women Taking Bisphosphonates Released April 1, 2013 Dima L. Diab, MD 1, and Nelson B. Watts, MD 2 ( 1 Cincinnati VA Medical Center, Cincinnati, OH, 2 Mercy Health

More information

Bone 45 (2009) Contents lists available at ScienceDirect. Bone. journal homepage:

Bone 45 (2009) Contents lists available at ScienceDirect. Bone. journal homepage: Bone 45 (2009) 843 852 Contents lists available at ScienceDirect Bone journal homepage: www.elsevier.com/locate/bone Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation? Philippe

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 Review of the dossier of the medicinal product included on the list of reimbursable medicines for a period

More information

The International Academy of Oral Medicine and Toxicology. IAOMT Position Paper on Human Jawbone Osteonecrosis

The International Academy of Oral Medicine and Toxicology. IAOMT Position Paper on Human Jawbone Osteonecrosis The International Academy of Oral Medicine and Toxicology IAOMT Position Paper on Human Jawbone Osteonecrosis Presented for Review- March 6, 2008 The International Academy of Oral Medicine and Toxicology

More information

Bisphosphonates can effectively inhibit bone resorption

Bisphosphonates can effectively inhibit bone resorption RESEARCH Vascular Alterations in the Sprague-Dawley Rat Mandible During Intravenous Bisphosphonate Therapy Chestine S. Guevarra, DMD, MS 1,2 James L. Borke, PhD 3 Mark R. Stevens, DDS 4 Fredrick C. Bisch,

More information

Practical Considerations for Treatment of Patients taking Bisphosphonate Medications: An Update

Practical Considerations for Treatment of Patients taking Bisphosphonate Medications: An Update Gareth Brock Kate Barker, Christopher J Butterworth and Simon Rogers Practical Considerations for Treatment of Patients taking Bisphosphonate Medications: An Update Abstract: Osteonecrosis of the jaw bisphosphonate-related

More information

Bone Health in Patients with Multiple Myeloma

Bone Health in Patients with Multiple Myeloma Bone Health in Patients with Multiple Myeloma Amrita Y. Krishnan, MD Director Judy and Bernard Briskin Myeloma Center City of Hope Comprehensive Cancer Center Bone Health Bisphosphonates in Space Bone

More information

Available online at British Journal of Oral and Maxillofacial Surgery 49 (2011)

Available online at  British Journal of Oral and Maxillofacial Surgery 49 (2011) Available online at www.sciencedirect.com British Journal of Oral and Maxillofacial Surgery 49 (2011) 251 257 Leading article Bisphosphonate osteonecrosis of the jaw a literature review of UK policies

More information